Tabula Rasa Healthcare (NASDAQ:TRHC) & Its Competitors Financial Review

Tabula Rasa Healthcare (NASDAQ: TRHC) is one of 18 publicly-traded companies in the “Medical Software & Technology Services” industry, but how does it weigh in compared to its peers? We will compare Tabula Rasa Healthcare to related businesses based on the strength of its analyst recommendations, dividends, institutional ownership, profitability, earnings, risk and valuation.

Institutional and Insider Ownership

27.9% of Tabula Rasa Healthcare shares are owned by institutional investors. Comparatively, 60.2% of shares of all “Medical Software & Technology Services” companies are owned by institutional investors. 45.8% of Tabula Rasa Healthcare shares are owned by company insiders. Comparatively, 26.7% of shares of all “Medical Software & Technology Services” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares Tabula Rasa Healthcare and its peers gross revenue, earnings per share (EPS) and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
Tabula Rasa Healthcare $108.83 million $2.26 million -35.34
Tabula Rasa Healthcare Competitors $376.98 million $34.79 million 8.33

Tabula Rasa Healthcare’s peers have higher revenue and earnings than Tabula Rasa Healthcare. Tabula Rasa Healthcare is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Tabula Rasa Healthcare and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Tabula Rasa Healthcare -10.27% -9.58% -4.51%
Tabula Rasa Healthcare Competitors -18.28% -11.68% -2.04%

Analyst Ratings

This is a summary of recent ratings and target prices for Tabula Rasa Healthcare and its peers, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tabula Rasa Healthcare 0 1 4 0 2.80
Tabula Rasa Healthcare Competitors 76 407 782 12 2.57

Tabula Rasa Healthcare presently has a consensus price target of $24.60, indicating a potential downside of 5.93%. As a group, “Medical Software & Technology Services” companies have a potential upside of 8.77%. Given Tabula Rasa Healthcare’s peers higher possible upside, analysts plainly believe Tabula Rasa Healthcare has less favorable growth aspects than its peers.

Summary

Tabula Rasa Healthcare peers beat Tabula Rasa Healthcare on 6 of the 11 factors compared.

About Tabula Rasa Healthcare

Tabula Rasa HealthCare, Inc. (Tabula Rasa), formerly CareKinesis, Inc., is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs. It also provides risk adjustment services, which help its clients to properly characterize a patient’s acuity, or severity of health condition, and optimize the associated payments for care. The Company serves approximately 100 healthcare organizations that focus on populations with complex healthcare needs and extensive medication requirements. Its products and services are built around the Medication Risk Mitigation Matrix, or MRM Matrix.

Receive News & Ratings for Tabula Rasa Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply